An overview of tumor pathology in hereditary breast cancer
| Gene with pathogenic variant | Estrogen-receptor–positive tumor | Estrogen-receptor–negative tumor | Triple-negative tumor |
|---|---|---|---|
| BRCA1 | Increasingly positive after age 50 | +++ particularly before age 50 | +++ particularly before age 50 |
| BRCA2 | ++ | Over-representation,a but still primarily estrogen-receptor–positive | Over-representation,a but still primarily estrogen-receptor–positive |
| PALB2 | ++ | Over-representation,a but still primarily estrogen-receptor–positive | Over-representation,a but still primarily estrogen-receptor–positive |
| ATM | +++ | ||
| CHEK2 | +++ | ||
| CDH1 | +++ | ||
| TP53 | +++ | ||
| BARD1 | +++ | +++ | |
| RAD51C | +++ | +++ | |
| RAD51D | +++ | +++ |
↵a Estrogen receptor tumors are more common than in the general population but are still not the predominant type of tumor pathology.
+ = relative prevalence